Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04228965 · ClinicalTrials.gov registry record · Phase 4
Cannabis and Tobacco Co-use Study
A Phase 4 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 4
- Development phase
- 181
- Enrollment target
NCT04228965 is a Phase 4 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 181 participants.
The verdict
NCT04228965, a Phase 4 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 181 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand tobacco outcomes using a well-known stop smoking medication, varenicline, and financial incentives with tobacco users. The investigators are also interested in how cannabis/marijuana and tobacco interact during a tobacco quit attempt. All participants will receive tobacco cessation treatment (varenicline) for 12 weeks. This study will recruit adult tobacco users (ages 18-40) who are motivated to quit smoking cigarettes.
Interventions
- DRUG Varenicline
- BEHAVIORAL Contingency Management
- BEHAVIORAL Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2020-01-28 |
| Est. Completion | 2024-09-13 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04228965
The ClinicalTrials.gov registry entry for NCT04228965 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 181 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Varenicline is the first listed.
NCT04228965 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04228965 about?
NCT04228965 is a clinical study titled "Cannabis and Tobacco Co-use Study". The purpose of this study is to better understand tobacco outcomes using a well-known stop smoking medication, varenicline, and financial incentives with tobacco users. The investigators are also interested in how cannabis/marijuana and tobacco interact during a tobacco quit attempt. All participant...
What is the current status of trial NCT04228965?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 181 participants. The study started on 2020-01-28. Estimated completion is 2024-09-13.
What interventions are being tested in trial NCT04228965?
The interventions under investigation include: Varenicline (DRUG), Contingency Management (BEHAVIORAL), Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT04228965?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.